BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30707324)

  • 1. Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma.
    Abdel-Rahman O; Cheung WY
    Med Oncol; 2019 Feb; 36(3):26. PubMed ID: 30707324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based assessment of the National Comprehensive Cancer Network recommendations for baseline imaging of rectal cancer.
    Abdel-Rahman O; Cheung WY
    J Comp Eff Res; 2019 Oct; 8(14):1167-1172. PubMed ID: 31638428
    [No Abstract]   [Full Text] [Related]  

  • 3. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
    Abdel-Rahman O
    Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
    Abdel-Rahman O
    Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?
    Abdel-Rahman O
    J Comp Eff Res; 2019 Feb; 8(3):157-163. PubMed ID: 30624081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is routine baseline brain imaging needed for all newly diagnosed non-small-cell lung cancer patients?
    Abdel-Rahman O
    J Comp Eff Res; 2019 Jun; 8(8):569-575. PubMed ID: 31116030
    [No Abstract]   [Full Text] [Related]  

  • 7. North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients.
    Preisser F; Mazzone E; Nazzani S; Marchioni M; Bandini M; Tian Z; Saad F; Soulières D; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Br J Cancer; 2018 Dec; 119(12):1552-1556. PubMed ID: 30425350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.
    Zhang N; Gu J; Yin L; Wu J; Du MY; Ding K; Huang T; He X
    Oncotarget; 2016 Dec; 7(49):81389-81401. PubMed ID: 27835609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):695-701. PubMed ID: 28276812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.
    Nagaoka S; Itano S; Ishibashi M; Torimura T; Baba K; Akiyoshi J; Kurogi J; Matsugaki S; Inoue K; Tajiri N; Takada A; Ando E; Kuromatsu R; Kaida H; Kurogi M; Koga H; Kumashiro R; Hayabuchi N; Kojiro M; Sata M
    Liver Int; 2006 Sep; 26(7):781-8. PubMed ID: 16911459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
    Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T; Harrison B; Delmenico L; Dowling D
    J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
    Chen YK; Hsieh DS; Liao CS; Bai CH; Su CT; Shen YY; Hsieh JF; Liao AC; Kao CH
    Anticancer Res; 2005; 25(6C):4719-25. PubMed ID: 16334166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.